Crossmark

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy

Crossref DOI link: https://doi.org/10.1073/pnas.1605731113

Published Online: 2016-09-12

Published Print: 2016-09-27

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Hammond, Suzan M. https://orcid.org/0000-0002-5640-7569
Hazell, Gareth

Shabanpoor, Fazel

Saleh, Amer F.

Bowerman, Melissa

Sleigh, James N. https://orcid.org/0000-0002-3782-9045
Meijboom, Katharina E.

Zhou, Haiyan

Muntoni, Francesco

Talbot, Kevin

Gait, Michael J.

Wood, Matthew J. A.
Funding

Funding for this research was provided by:

Medical Research Council (G0900887)

Medical Research Council (U105178803)
License Information

Version of Record valid from 2016-09-12
More Information

Publication History

Published: 2016-09-12